Wall Street researchers have revised their price targets for Tesla stock — at present, no clear consensus has emerged.

With stock valuations climbing steadily over the past two years and artificial intelligence (AI) budgets of the big tech firms climbing by the year, it's only prudent to wonder if a bubble is in the ...

U.S. stock futures moved marginally higher on Thursday following the latest flurry of U.S. economic reports. Investors received the first reading on Q4 GDP. The data showed the U.S. economy expanded ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands ...

U.S. stock futures point mostly higher as investors react to corporate earnings, Apple is slated to report results after the bell, and Tesla stock gains after the company delivers an upbeat update on ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Before The DeepSeek Sell-Off. In this article, we are ...

Oppenheimer initiated coverage on Alumis Inc (NASDAQ:ALMS) with an Outperform rating and a price target of $32.00. The firm's analysts highlighted the biopharmaceutical company's focus on developing ...

With the stock market going through its first earnings season of 2025, companies are making important announcements. This ...